Rigel Pharmaceuticals has enrolled the first patient in a Phase I trial to evaluate fostamatinib as a treatment for sickle ...

In 1997, Johnson was appointed to Miami-Dade Circuit Court, where he established the first Juvenile Drug Court in the county, ...

While much attention is given to the painful crises, anaemia, and organ damage caused by SCD, its impact on vision is equally ...

Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the ...

Abnormal cells can clog blood vessels, leading to severe pain episodes and restricting oxygen delivery to vital organs ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the first patient has been enrolled in a Phase 1 study evaluating ...

Rigel has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, fostamatinib, to ...

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

Campbellsville volleyball players pose with some of the KYDR volunteers in Brevard, N.C., last fall. KYDR volunteers are ...

Rigel Pharmaceuticals (RIGL) announced the first patient has been enrolled in a Phase 1 study evaluating the safety and tolerability of ...

Lilian Chepkoech, a mother from Kericho county, is seeking financial assistance to buy an oxygen cylinder for her daughter ...